Purchase Order AG7B31P170023
Award Date 5/11/17
Potential Completion Date 11/11/17
Potential Value $5.1K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
New Orleans, LA 70124, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
3
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. government awarded a purchase order contract valued at $4,076.85 to Genscript USA Inc. for monoclonal antibody production. The contract, awarded on April 27, 2016, with an ultimate completion date of July 28, 2016, utilized firm fixed price pricing with no set-aside designation. Work was performed at Genscript's facility in Piscataway, New Jersey, and the funding agency was a civilian federal entity within the Southeast Area region. Genscript USA Inc. is a biotechnology company...
- The U.S. government awarded a purchase order valued at $5,075.85 to Genscript USA Inc., a biotechnology company headquartered in Piscataway, New Jersey, for monoclonal antibody products. The contract, awarded on September 19, 2016, with an ultimate completion date of March 20, 2017, was issued under a firm fixed-price pricing structure by a civilian federal agency (Southeast Area). No set-aside designation was applied to this award. The place of performance is located in Piscataway, New...
- The U.S. government awarded a $12,411.55 firm fixed-price purchase order to Genscript USA Inc. on September 15, 2021, for animal immunization, cell fusion, subcloning, antibody production, purification, and sequencing services. The contract, which was completed on March 16, 2022, was funded through a civilian federal agency within the Southeast Area and performed at Genscript's facility in Piscataway, New Jersey. No set-aside designation was applied to this award. Genscript USA Inc., a...
- This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The contract, valued at $3,800.00, is for custom monoclonal antibody production services to support NIAID's biomedical research and public health initiatives. This contract does not have a set-aside designation. Genscript...
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to Genscript USA Inc., a for-profit biotechnology company based in Piscataway, New Jersey. The $164,700.00 firm fixed-price purchase order is for monoclonal antibodies and plasmids services, with a completion date of June 14, 2026. The contract does not have a set-aside designation. Genscript is a key supplier of...
- This federal contract award was issued by the Midwest Area component of a civilian federal agency to Genscript USA Inc., a biotechnology company based in New Jersey. The $13,420.52 firm fixed-price purchase order is for the supply of proteins and antibodies. The contract does not have a set-aside designation. Genscript is a provider of specialized molecular biology products and services to various government agencies, including the Department of Health and Human Services, Department of...
- This $8,435.16 firm fixed price purchase order was awarded by the National Institute of Allergy and Infectious Diseases, part of the Department of Health and Human Services' National Institutes of Health, to Genscript USA Inc., a for-profit biotechnology company located in Piscataway, New Jersey. The contract is for antibody production services, with a completion date of June 15, 2018. Genscript specializes in providing a range of biomedical research and public health products and services to...
- The Department of Agriculture Agricultural Research Service Field Research Implementation and Information Delivery awarded a purchase order valued at $24,796.45 to Genscript USA Inc. The contract calls for Genscript to provide custom anti car I 2 monoclonal antibody in support of USDA research efforts. Specifically, the solicitation requested quotes for the antibody meeting associated technical specifications, price breakdowns, and descriptive literature demonstrating compliance. The place of...
- The U.S. government awarded a $3,194.98 firm fixed-price purchase order to Genscript USA Inc. on May 5, 2015, for custom gene synthesis services. The contract, with an ultimate completion date of September 30, 2015, was funded by a civilian agency within the Midwest Area and performed at the contractor's facility in Piscataway, New Jersey. No set-aside designation was applied to this award. Genscript USA Inc., a biotechnology company specializing in advanced molecular biology services, has...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed price purchase order to GenScript USA Inc., a for-profit biotechnology company, to provide custom monoclonal antibody production services. The $13,758.30 contract has an October 16, 2019 completion date and was awarded on August 14, 2019. GenScript, based in Piscataway, New Jersey, specializes in gene synthesis, protein production, and other...